Previous close | 33.950 |
Open | 32.750 |
Bid | 35.650 x N/A |
Ask | 35.950 x N/A |
Day's range | 32.750 - 36.400 |
52-week range | 26.600 - 65.600 |
Volume | |
Avg. volume | 1,465,370 |
Market cap | 9.999B |
Beta (5Y monthly) | -0.08 |
PE ratio (TTM) | N/A |
EPS (TTM) | -1.480 |
Earnings date | 26 Mar 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 62.02 |
Keymed Biosciences Inc. (HKEX: 02162) today announced its 2023 annual results, along with recent pipeline highlights and corporate updates.